Matthew Sackett, MD
Clinical Cardiac Electrophysiology · Lynchburg, VANPI 1386628774
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Atricure, Inc. at 45.5% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in VA, where the typical reported total is $19,771.
Across 139 payments — averaging $122.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$8K
- Impulse Dynamics (USA) Inc.$3K
- Medtronic$2K
- Abbott$935
- Biosense Webster, Inc.$868
- Boston Scientific$703
- plus $2K from 10 others
Across 54 payments — averaging $3650.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$140K
- Impulse Dynamics (USA) Inc.$54K
- Medtronic$3K
What the payments were for
- Consulting fees$4,27525%
- Speaking & faculty fees$2,70016%
- Travel & lodging$3,56021%
- Food & beverage$6,54038%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 10 | $7,770 |
| Impulse Dynamics (USA) Inc. | 11 | $3,076 |
| Medtronic(2 entities) | 38 | $1,970 |
| Abbott | 10 | $935 |
| Biosense Webster, Inc. | 21 | $868 |
| Boston Scientific | 10 | $703 |
| ZOLL Respicardia, Inc. | 4 | $672 |
| Cvrx, Inc. | 5 | $267 |
| Irhythm Technologies, Inc. | 3 | $227 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $192 |
| Volta Medical Inc | 1 | $97 |
| Novartis | 5 | $96 |
| Elutia, Inc. | 6 | $91 |
| Cardiva Medical, Inc. | 3 | $71 |
| Edwards Lifesciences | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$7,650
- OPTIMIZER$5,624
- ATRICLIP LAA EXCLUSION SYSTEM$900
- remede System$618
- Micra$466
- COBALT DR MRI SURESCAN$317
- Carto 3$225
- ENSITE PRECISION$219
- ZIO XT Patch$163
- AMPLATZER AMULET$148
- WATCHMAN FLX$145
- EnSite Precision Cardiac Mapping System$142
- PulseSelect$125
- ARCTIC FRONT ADVANCE$121
- Barostim Neo System$111
- Farapulse$103
- AFFERA MAPPING SYSTEM$103
How this compares
$17,087 in reported general payments places this provider in the 45th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 429 | $325,179 |
| EntrestoSacubitril/Valsartan | 157 | $131,097 |
| XareltoRivaroxaban | 99 | $88,588 |
| JardianceEmpagliflozin | 18 | $25,124 |
| CorlanorIvabradine Hcl | 24 | $15,023 |
| MultaqDronedarone Hcl | 15 | $11,400 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 17 | $5,687 |
| Propafenone Hcl ErPropafenone Hcl | 21 | $4,666 |
| Ivabradine Hcl | 17 | $2,709 |
| Propafenone Hcl | 75 | $2,664 |
| Flecainide Acetate | 62 | $2,608 |
| Metoprolol Succinate | 240 | $2,021 |
| Carvedilol | 197 | $1,474 |
| Amiodarone Hcl | 118 | $1,422 |
| SotalolSotalol Hcl | 106 | $1,294 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $96 | $131,097157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Lynchburg
- Chinmaya MareddyLynchburg$22K
- Jose SilvaLynchburg$13K
- Kenneth EllenbogenRichmond$360K
- Brett AtwaterFairfax$319K
- Oliver MonfrediCharlottesville$231K
- Peem LorvidhayaFredericksburg$230K
- Erich KiehlNewport News$181K
- Emmanuel EkanemWinchester$132K
- Pamela MasonCharlottesville$130K
- Ajay PillaiRichmond$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.